Pleural Catheters Versus Thoracoscopic Pleurodesis
The goal of this clinical research study is to compare 2 different methods for treating a pleural effusion. Researchers also want to learn how the treatment you receive effects your quality of life (your ability to do the things you like to do and how happy you feel.
Checked against the public recordLast updated Apr 11, 2016 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- M.D. Anderson Cancer Center
- Interventions being studied
- Behavioral: MDASI Questionnaire
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: 1. Patients with MPE who are suitable for either pleural catheter placement or thoracoscopic pleurodesis who subsequently have either procedure performed 2. Sufficient mental capacity to answer SF-6D and Borg score questions 3. Age 18 or older 4. Life expectancy \> 2 months 5. English or Spanish speaking Exclusion Criteria: 1. Patients undergoing pleurodesis for benign disease (e.g., spontaneous pneumothorax) 2. Inability or unwillingness to give informed consent 3. Inability to perform phone call follow-up 4. Pregnancy 5. Previous intrapleural therapy for MPE 6. Prior radiation therapy encompassing the entire hemithorax 7. Chylous effusions associated with malignant disease 8. Bilateral effusions requiring bilateral pleurodesis
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- University of Texas MD Anderson Cancer CenterHouston, Texas
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Apr 11, 2016. Always confirm current availability with the study team.